Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Soleo Health.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Soleo Health
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
2801 Network Blvd., Suite 505, Frisco, Texas 75034, US
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

LEQVIO (inclisiran) injection is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH).


Lead Product(s): Inclisiran

Therapeutic Area: Cardiology/Vascular Diseases Product Name: Leqvio

Highest Development Status: ApprovedProduct Type: Large molecule

Partner/Sponsor/Collaborator: Novartis Pharmaceuticals Corporation

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership July 26, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Specialty pharmacy partners to dispense nationwide RADICAVA ORS® (edaravone) oral suspension, commercialized by Mitsubishi Tanabe Pharma America, Inc. (MTPA), which commercializes approved pharmaceutical products in North America.


Lead Product(s): Edaravone

Therapeutic Area: Neurology Product Name: Radicava ORS

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Mitsubishi Tanabe Pharma

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership June 07, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Soleo Health offers differentiated capabilities through its ability to collect real-world data and generate intelligent outcomes from VYVGART patients with its exclusive and proprietary clinical outcomes program, SoleMetrics®.


Lead Product(s): Efgartigimod

Therapeutic Area: Immunology Product Name: Vyvgart

Highest Development Status: ApprovedProduct Type: Large molecule

Partner/Sponsor/Collaborator: Argenx

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership January 24, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Soleo Health was chosen as a limited distributor of XEMBIFY. This is Grifols’ first 20% immune globulin.


Lead Product(s): Immune globulin human-klhw

Therapeutic Area: Immunology Product Name: Undisclosed

Highest Development Status: ApprovedProduct Type: Large molecule

Partner/Sponsor/Collaborator: Grifols International

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement April 01, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY